Hank Hauser has 25 years of medical device experience, beginning as a radiology and cardiovascular technician in the cardiology catheterization lab before moving into a clinical research field role. Prior to joining Alucent Biomedical, Hank most recently served as the Global Vice President of Clinical Operations for Keystone Heart, a cerebral embolic protection device company.
Hank has experience in managing all aspects of global clinical studies. This work has resulted in multiple FDA and CE Mark approvals and ultimately the acquisition of several companies, including: Vessix Vascular to Boston Scientific; Ulthera, Inc. to Merz; and Rubicon to Boston Scientific. He received a Bachelor of Science degree in radiology from the University of Oklahoma Health Sciences Center.